RU2019128667A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2019128667A3 RU2019128667A3 RU2019128667A RU2019128667A RU2019128667A3 RU 2019128667 A3 RU2019128667 A3 RU 2019128667A3 RU 2019128667 A RU2019128667 A RU 2019128667A RU 2019128667 A RU2019128667 A RU 2019128667A RU 2019128667 A3 RU2019128667 A3 RU 2019128667A3
- Authority
- RU
- Russia
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2019128667A RU2745265C2 (en) | 2019-09-12 | 2019-09-12 | Novel 2-(imidazol-4-yl)-ethanamide of pentandioic-1,5 acid compositions for treating and preventing viral diseases |
| EA202090135A EA038170B1 (en) | 2019-09-12 | 2020-01-23 | Pentandioic-1,5 acid 2-(imidazol-4-yl)ethanamide formulations for treating and preventing viral diseases |
| UAA202000680A UA125151C2 (en) | 2019-09-12 | 2020-02-04 | Novel 2-(imidazol-4-yl)-ethanamide pentanedioic-1,5 acid compositions for treatment and prevention of viral diseases |
| PCT/RU2020/050219 WO2021049980A1 (en) | 2019-09-12 | 2020-09-10 | Novel compositions for treatment and prophylaxis of viral diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2019128667A RU2745265C2 (en) | 2019-09-12 | 2019-09-12 | Novel 2-(imidazol-4-yl)-ethanamide of pentandioic-1,5 acid compositions for treating and preventing viral diseases |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2020111926A Division RU2782532C2 (en) | 2020-03-24 | New formulations of 2-(imidazole-4-yl)-ethanamide pentanedioic-1,5 acid for the treatment and prevention of viral diseases | |
| RU2020111932A Division RU2791902C2 (en) | 2020-03-24 | Novel formulations of 2-(imidazol-4-yl)-ethanamide of pentanedioic acid for treatment and prevention of viral diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2019128667A RU2019128667A (en) | 2021-03-12 |
| RU2019128667A3 true RU2019128667A3 (en) | 2021-03-12 |
| RU2745265C2 RU2745265C2 (en) | 2021-03-22 |
Family
ID=74873846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2019128667A RU2745265C2 (en) | 2019-09-12 | 2019-09-12 | Novel 2-(imidazol-4-yl)-ethanamide of pentandioic-1,5 acid compositions for treating and preventing viral diseases |
Country Status (3)
| Country | Link |
|---|---|
| EA (1) | EA038170B1 (en) |
| RU (1) | RU2745265C2 (en) |
| UA (1) | UA125151C2 (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4920974B1 (en) * | 1970-06-01 | 1974-05-29 | ||
| RU2141483C1 (en) * | 1997-07-04 | 1999-11-20 | Небольсин Владимир Евгеньевич | Peptide derivatives or their pharmaceutically acceptable salts, method of their synthesis, use and pharmaceutical composition |
| RU2665688C2 (en) * | 2013-04-12 | 2018-09-04 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Dicarboxylic acid bisamide derivatives, their application, the pharmaceutical composition on their basis, methods for their production |
| RU2679636C1 (en) * | 2018-10-29 | 2019-02-12 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | New method of the n,n'-bis[2-(1h-imidazol-4-yl)ethyl]malonamide obtaining |
-
2019
- 2019-09-12 RU RU2019128667A patent/RU2745265C2/en active
-
2020
- 2020-01-23 EA EA202090135A patent/EA038170B1/en unknown
- 2020-02-04 UA UAA202000680A patent/UA125151C2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA202090135A1 (en) | 2021-03-31 |
| EA038170B1 (en) | 2021-07-19 |
| RU2019128667A (en) | 2021-03-12 |
| UA125151C2 (en) | 2022-01-19 |
| RU2745265C2 (en) | 2021-03-22 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PD4A | Correction of name of patent owner | ||
| QB4A | Licence on use of patent |
Free format text: LICENCE FORMERLY AGREED ON 20210722 Effective date: 20210722 |